Exact Mass: 261.1212

Exact Mass Matches: 261.1212

Found 144 metabolites which its exact mass value is equals to given mass value 261.1212, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Lotaustralin

(R)-2-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanenitrile

C11H19NO6 (261.1212)


Lotaustralin is a cyanogenic glycoside. Lotaustralin is a natural product found in Osteospermum ecklonis, Lotus arenarius, and other organisms with data available. Epilotaustralin is found in cereals and cereal products. Epilotaustralin is isolated from Triticum monococcum (wheat). Glycoside from Trifolium repens (white clover) and other plants Lotaustralin is a cyanogenic glucoside isolated from Manihot esculenta [1].

   

Imazapyr

2-[5-methyl-4-oxo-5-(propan-2-yl)-4,5-dihydro-1H-imidazol-2-yl]pyridine-3-carboxylic acid

C13H15N3O3 (261.1113)


CONFIDENCE standard compound; INTERNAL_ID 2630 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

methapyrilene

N-[2-(dimethylamino)ethyl]-N-[(thiophen-2-yl)methyl]pyridin-2-amine

C14H19N3S (261.13)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

   

Heterodendrin

Heterodendrin

C11H19NO6 (261.1212)


   

Mycosporine

SCHEMBL19129760

C11H19NO6 (261.1212)


   

Yellow OB

1-[2-(2-Methylphenyl)diazenyl]-2-naphthalenamine

C17H15N3 (261.1266)


   

Glycyl-Tryptophan

2-[(2-Amino-1-hydroxyethylidene)amino]-3-(1H-indol-3-yl)propanoate

C13H15N3O3 (261.1113)


Glycyl-Tryptophan is a dipeptide composed of glycine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Epidermin

3-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


Epidermin is found in cereals and cereal products. Epidermin is a constituent of barley (Hordeum vulgare) Constituent of barley (Hordeum vulgare). Epidermin is found in barley and cereals and cereal products.

   

Tryptophyl-Glycine

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}acetate

C13H15N3O3 (261.1113)


Tryptophyl-Glycine is a dipeptide composed of tryptophan and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Camelinin

1-isothiocyanato-10-(Methylsulfinyl)decane, 9ci

C12H23NOS2 (261.1221)


Camelinin is found in fats and oils. Camelinin is isolated from seeds of Camelina sativa (false flax). Isolated from seeds of Camelina sativa (false flax). Camelinin is found in fats and oils.

   

Succinyl Carnitine

(3R)-3-[(3-carboxypropanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C11H19NO6 (261.1212)


Succinylcarnitine is an acylcarnitine. More specifically, it is an succinic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Succinylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine Succinylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980), it has been identified in the human placenta (PMID: 32033212 ). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

O-methylmalonyl-L-carnitine

3-{[(2R)-1-carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy}-2-methyl-3-oxopropanoate

C11H19NO6 (261.1212)


O-methylmalonyl-L-carnitine is considered to be practically insoluble (in water) and acidic

   

Thenyldiamine

N-[2-(dimethylamino)ethyl]-N-[(thiophen-3-yl)methyl]pyridin-2-amine

C14H19N3S (261.13)


Thenyldiamine is an ethylenediamine H1-antihistamine.

   

O-Methylmalonylcarnitine

3-{[1-carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy}-2-methyl-3-oxopropanoate

C11H19NO6 (261.1212)


O-Methylmalonylcarnitine is an acylcarnitine. More specifically, it is an methylmalonic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. O-Methylmalonylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine O-Methylmalonylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-[1-Carboxy-2-(trimethylazaniumyl)ethoxy]-5-oxopentanoate

5-[1-Carboxy-2-(trimethylazaniumyl)ethoxy]-5-oxopentanoic acid

C11H19NO6 (261.1212)


   

Acetamide, N-[2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethyl]-

Acetamide, N-[2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethyl]-

C13H15N3O3 (261.1113)


   

O-Succinylcarnitine

3-[(3-Carboxypropanoyl)oxy]-4-(trimethylammonio)butanoic acid

C11H19NO6 (261.1212)


   

(2S,5R)-3,3-Dimethyl-2-(2-phenylethyl)-4-thia-1-azabicyclo[3.2.0]heptan-7-one

(2S,5R)-3,3-Dimethyl-2-(2-phenylethyl)-4-thia-1-azabicyclo[3.2.0]heptan-7-one

C15H19NOS (261.1187)


   

N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-nitrosoacetamide

N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-oxoacetohydrazide

C13H15N3O3 (261.1113)


   

Epiheterodendrin

3-methyl-2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


Epiheterodendrin is a member of the class of compounds known as cyanogenic glycosides. Cyanogenic glycosides are glycosides in which the aglycone moiety contains a cyanide group. Epiheterodendrin is soluble (in water) and a very weakly acidic compound (based on its pKa). Epiheterodendrin can be found in barley, which makes epiheterodendrin a potential biomarker for the consumption of this food product.

   

2-Decene-4,6,8-triynoic acid-2-Phenylethylamide

2-Decene-4,6,8-triynoic acid-2-Phenylethylamide

C18H15NO (261.1154)


   

(2E,4E,6E)-N-(2-methylpropyl)-7-(2-thienyl)-2,4-6-heptatrienamide|(2E,4E,6E)-N-isobutyl-7-(2-thienyl)-2,4,6-heptatrienamide|(2E,4E,6E)-N-isobutyl-7-(2-thienyl)heptatrienamide|N-Isobutylotanthusic acid amide|Otanthussaeure-isobutylamid

(2E,4E,6E)-N-(2-methylpropyl)-7-(2-thienyl)-2,4-6-heptatrienamide|(2E,4E,6E)-N-isobutyl-7-(2-thienyl)-2,4,6-heptatrienamide|(2E,4E,6E)-N-isobutyl-7-(2-thienyl)heptatrienamide|N-Isobutylotanthusic acid amide|Otanthussaeure-isobutylamid

C15H19NOS (261.1187)


   
   

Me glycoside,N,2-di-Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

Me glycoside,N,2-di-Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

C11H19NO6 (261.1212)


   

2-hydroxymethylbutanenitrile beta-D-glucopyranoside|supinanitriloside A

2-hydroxymethylbutanenitrile beta-D-glucopyranoside|supinanitriloside A

C11H19NO6 (261.1212)


   

(1S, 2R, 2S)-form-Isoleucinopine|isoleucinopine

(1S, 2R, 2S)-form-Isoleucinopine|isoleucinopine

C11H19NO6 (261.1212)


   

Me glycoside,N,4-di-Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

Me glycoside,N,4-di-Ac-beta-D-Pyranose-3-Amino-3,6-dideoxygalactose

C11H19NO6 (261.1212)


   

methyl 5-acetamido-1,7-anhydro-3,5-dideoxy-beta-D-galacto-octulopyranoside

methyl 5-acetamido-1,7-anhydro-3,5-dideoxy-beta-D-galacto-octulopyranoside

C11H19NO6 (261.1212)


   

(2R)-2-methyl-3-(beta-D-glucopyranosyloxy)butanenitrile

(2R)-2-methyl-3-(beta-D-glucopyranosyloxy)butanenitrile

C11H19NO6 (261.1212)


   

Na-demethyl-20-deethylsuaveolione|sellowiine

Na-demethyl-20-deethylsuaveolione|sellowiine

C17H15N3 (261.1266)


   

Tryptophylglycine

Tryptophylglycine

C13H15N3O3 (261.1113)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.392

   

Gly-Trp

2-[2-amino-3-(1H-indol-3-yl)propanamido]acetic acid

C13H15N3O3 (261.1113)


A dipeptide formed from glycine and L-tryptophan residues.

   

C11H19NO6_Butanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl

NCGC00384570-01_C11H19NO6_Butanenitrile, 2-(beta-D-glucopyranosyloxy)-2-methyl-

C11H19NO6 (261.1212)


   

C11H19NO6_3-(beta-D-Glucopyranosyloxy)-2-methylbutanenitrile

NCGC00385866-02_C11H19NO6_3-(beta-D-Glucopyranosyloxy)-2-methylbutanenitrile

C11H19NO6 (261.1212)


   

Lotaustralin

(R)-2-methyl-2-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanenitrile

C11H19NO6 (261.1212)


Lotaustralin is a cyanogenic glycoside. Lotaustralin is a natural product found in Osteospermum ecklonis, Lotus arenarius, and other organisms with data available. Lotaustralin is a cyanogenic glucoside isolated from Manihot esculenta [1].

   

Mycosporine serinol

Mycosporine serinol

C11H19NO6 (261.1212)


   

Imazapyr

Imazapyr

C13H15N3O3 (261.1113)


D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

Imazapyr_Na-Adduct

Imazapyr_Na-Adduct

C13H15N3O3 (261.1113)


   

Lotaustralin_minor

Lotaustralin_minor

C11H19NO6 (261.1212)


   

Lotaustralin_major

Lotaustralin_major

C11H19NO6 (261.1212)


   
   
   

TRP-Gly

2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoic acid

C13H15N3O3 (261.1113)


A dipeptide formed from L-tryptophan and glycine residues.

   

Epidermin

3-methyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

Camelinin

1-isothiocyanato-10-(Methylsulfinyl)decane, 9ci

C12H23NOS2 (261.1221)


   

CAR 4:1;O2

3-[(3-carboxypropanoyl)oxy]-4-(trimethylammonio)butanoate;succinylcarnitine

C11H19NO6 (261.1212)


   

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,3a-dihydroimidazo[4,5-b]pyridin-2-one

6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,3a-dihydroimidazo[4,5-b]pyridin-2-one

C12H16BN3O3 (261.1285)


   

ALLYL 2-ACETAMIDO-2-DEOXY-β-D-GLUCOPYRANOSIDE

ALLYL 2-ACETAMIDO-2-DEOXY-β-D-GLUCOPYRANOSIDE

C11H19NO6 (261.1212)


   

(E)-4-(4-Methoxystyryl)quinoline

(E)-4-(4-Methoxystyryl)quinoline

C18H15NO (261.1154)


   

1-(tert-butoxycarbonyl)-1H-indole-5-boronic acid

1-(tert-butoxycarbonyl)-1H-indole-5-boronic acid

C13H16BNO4 (261.1172)


   

5-(5-Borono-1H-indol-1-yl)pentanoic acid

5-(5-Borono-1H-indol-1-yl)pentanoic acid

C13H16BNO4 (261.1172)


   

N-phenethyl-2-phenyl-ethanamine

N-phenethyl-2-phenyl-ethanamine

C16H20ClN (261.1284)


   

Boc-Glu(OMe)-OH

Boc-Glu(OMe)-OH

C11H19NO6 (261.1212)


   

9-(4-chlorophenyl)-3-azaspiro[5.5]undec-9-ene

9-(4-chlorophenyl)-3-azaspiro[5.5]undec-9-ene

C16H20ClN (261.1284)


   

Benzenemethanaminium,N,N-dimethyl-N-(phenylmethyl)-, chloride (1:1)

Benzenemethanaminium,N,N-dimethyl-N-(phenylmethyl)-, chloride (1:1)

C16H20ClN (261.1284)


   

N-(TERT-BUTYLDIMETHYLSILYL)PHTHALIMIDE

N-(TERT-BUTYLDIMETHYLSILYL)PHTHALIMIDE

C14H19NO2Si (261.1185)


   

BENZYL-(1-P-TOLYLETHYL)AMINEHYDROCHLORIDE

BENZYL-(1-P-TOLYLETHYL)AMINEHYDROCHLORIDE

C16H20ClN (261.1284)


   

N-CBZ-1,2,3,6-tetrahydropyridin-4-ylboronic acid

N-CBZ-1,2,3,6-tetrahydropyridin-4-ylboronic acid

C13H16BNO4 (261.1172)


   

8-(4-fluorophenyl)-1,4-dioxaspiro[4.5]decane-8-carbonitrile

8-(4-fluorophenyl)-1,4-dioxaspiro[4.5]decane-8-carbonitrile

C15H16FNO2 (261.1165)


   

Boc-D-Glu-OMe

Boc-D-Glu-OMe

C11H19NO6 (261.1212)


   

Boc-D-2-aminoadipic acid

Boc-D-2-aminoadipic acid

C11H19NO6 (261.1212)


   
   

ethyl 2-(7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate

ethyl 2-(7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate

C15H16FNO2 (261.1165)


   

Benzenemethanamine,a-methyl-N-[(1R)-1-phenylethyl]-,hydrochloride (1:1), (aR)-

Benzenemethanamine,a-methyl-N-[(1R)-1-phenylethyl]-,hydrochloride (1:1), (aR)-

C16H20ClN (261.1284)


   

N-Boc-indole-2-boronic acid

N-Boc-indole-2-boronic acid

C13H16BNO4 (261.1172)


   

3-(BIPHENYL-4-YLOXY)-PHENYLAMINE

3-(BIPHENYL-4-YLOXY)-PHENYLAMINE

C18H15NO (261.1154)


   

3,3-({[(2-Methyl-2-propanyl)oxy]carbonyl}imino)dipropanoic acid (non-preferred name)

3,3-({[(2-Methyl-2-propanyl)oxy]carbonyl}imino)dipropanoic acid (non-preferred name)

C11H19NO6 (261.1212)


   

2-Pyridinemethanol, a,a-diphenyl-

2-Pyridinemethanol, a,a-diphenyl-

C18H15NO (261.1154)


   

1-(2,4,5-TRICHLORO-PHENYL)-PYRROLE-2,5-DIONE

1-(2,4,5-TRICHLORO-PHENYL)-PYRROLE-2,5-DIONE

C12H20ClNO3 (261.1132)


   

Ethyl 5-amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylate

Ethyl 5-amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylate

C13H15N3O3 (261.1113)


   

methyl 4-bromo-3-methoxythiophene-2-carboxylate

methyl 4-bromo-3-methoxythiophene-2-carboxylate

C11H19NO6 (261.1212)


   

4-Amino-2,6-diphenylphenol

4-Amino-2,6-diphenylphenol

C18H15NO (261.1154)


   

6-FLUORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

6-FLUORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-3-CARBOXYLIC ACID ETHYL ESTER

C15H16FNO2 (261.1165)


   

2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)thioxanthen-9-one

2-(1,1,1,2,3,3,3-heptadeuteriopropan-2-yl)thioxanthen-9-one

C16H7D7OS (261.1205)


   

ethyl 4,4-difluoro-3-oxo-2-(piperidin-1-ylmethylene)butanoate

ethyl 4,4-difluoro-3-oxo-2-(piperidin-1-ylmethylene)butanoate

C12H17F2NO3 (261.1176)


   

3,5-Dimethoxy-N-(2-fluorobenzyl)aniline

3,5-Dimethoxy-N-(2-fluorobenzyl)aniline

C15H16FNO2 (261.1165)


   

2,5-Dimethoxy-N-(2-fluorobenzyl)aniline

2,5-Dimethoxy-N-(2-fluorobenzyl)aniline

C15H16FNO2 (261.1165)


   

2,4-Dimethoxy-N-(2-fluorobenzyl)aniline

2,4-Dimethoxy-N-(2-fluorobenzyl)aniline

C15H16FNO2 (261.1165)


   

3,5-Dimethoxy-N-(4-fluorobenzyl)aniline

3,5-Dimethoxy-N-(4-fluorobenzyl)aniline

C15H16FNO2 (261.1165)


   

(-)-bis[(s)-1-phenylethyl]amine hydrochloride

(-)-bis[(s)-1-phenylethyl]amine hydrochloride

C16H20ClN (261.1284)


   

(R,R)-(-)-2,3-DIPHENYLSUCCINICACID

(R,R)-(-)-2,3-DIPHENYLSUCCINICACID

C16H20ClN (261.1284)


   

Benzeneacetamide,N-1-naphthalenyl-

Benzeneacetamide,N-1-naphthalenyl-

C18H15NO (261.1154)


   

Diphenyl(4-pyridyl)methanol

Diphenyl(4-pyridyl)methanol

C18H15NO (261.1154)


   

1,4-DIPHENYLBUTAN-1-AMINE HYDROCHLORIDE

1,4-DIPHENYLBUTAN-1-AMINE HYDROCHLORIDE

C16H20ClN (261.1284)


   

1-(tert-butoxycarbonyl)indole-3-boronic acid

1-(tert-butoxycarbonyl)indole-3-boronic acid

C13H16BNO4 (261.1172)


   
   

l-1,2-Diphenyl-1-dimethylaminoethane hydrochloride

l-1,2-Diphenyl-1-dimethylaminoethane hydrochloride

C16H20ClN (261.1284)


   

3-(Benzyl(methyl)amino)-1-(thiophen-2-yl)propan-1-ol

3-(Benzyl(methyl)amino)-1-(thiophen-2-yl)propan-1-ol

C15H19NOS (261.1187)


   
   
   

1H-Indole-2-carboxylic acid, 1-(trimethylsilyl)-, ethyl ester

1H-Indole-2-carboxylic acid, 1-(trimethylsilyl)-, ethyl ester

C14H19NO2Si (261.1185)


   

[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde

[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde

C13H15N3O3 (261.1113)


   

Glycyltryptophan

Glycyltryptophan

C13H15N3O3 (261.1113)


   

Epiheterodendrin

Epiheterodendrin

C11H19NO6 (261.1212)


   

pentalenolactone E(1-)

pentalenolactone E(1-)

C15H17O4- (261.1127)


A monocarboxylic acid anion that is the conjugate base of pentalenolactone E, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Dihydroosmaronin

Dihydroosmaronin

C11H19NO6 (261.1212)


   

neopentalenolactone E

neopentalenolactone E

C15H17O4- (261.1127)


   
   

(2S)-2-[(2-azaniumylacetyl)amino]-3-(1H-indol-3-yl)propanoate

(2S)-2-[(2-azaniumylacetyl)amino]-3-(1H-indol-3-yl)propanoate

C13H15N3O3 (261.1113)


   

thenyldiamine

thenyldiamine

C14H19N3S (261.13)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

3-[1-Carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy-2-methyl-3-oxopropanoate

3-[1-Carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy-2-methyl-3-oxopropanoate

C11H19NO6 (261.1212)


   

3-[(2R)-1-carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy-2-methyl-3-oxopropanoate

3-[(2R)-1-carboxy-3-(trimethylazaniumyl)propan-2-yl]oxy-2-methyl-3-oxopropanoate

C11H19NO6 (261.1212)


   

Methylmalonyl-L-carnitine

Methylmalonyl-L-carnitine

C11H19NO6 (261.1212)


   

(2S,5R)-3,3-Dimethyl-2-(2-phenylethyl)-4-thia-1-azabicyclo[3.2.0]heptan-7-one

(2S,5R)-3,3-Dimethyl-2-(2-phenylethyl)-4-thia-1-azabicyclo[3.2.0]heptan-7-one

C15H19NOS (261.1187)


   

2-Methyl-5-phenyl-3,5-dihydropyrazolo[1,5-c]quinazoline

2-Methyl-5-phenyl-3,5-dihydropyrazolo[1,5-c]quinazoline

C17H15N3 (261.1266)


   

2,6-dimethoxy-N-(2-methylpyrazol-3-yl)benzamide

2,6-dimethoxy-N-(2-methylpyrazol-3-yl)benzamide

C13H15N3O3 (261.1113)


   

8-Methyl-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thione

8-Methyl-2-phenyl-1,2,4-triazaspiro[4.5]decane-3-thione

C14H19N3S (261.13)


   

(3Z,6Z)-dodeca-3,6-dien-1-yl sulfate

(3Z,6Z)-dodeca-3,6-dien-1-yl sulfate

C12H21O4S- (261.116)


An organosulfate oxoanion that is the conjugate base of (3Z,6Z)-dodeca-3,6-dien-1-yl hydrogen sulfate. Isolated from Daphnia pulex, it induces morphological changes of phytoplankton Scenedesmus gutwinskii.

   
   

1-[(Z)-3,4-dihydro-2H-naphthalen-1-ylideneamino]-3-propan-2-ylthiourea

1-[(Z)-3,4-dihydro-2H-naphthalen-1-ylideneamino]-3-propan-2-ylthiourea

C14H19N3S (261.13)


   

N-Trimethylsilylindoleacetic acid, methyl ester

N-Trimethylsilylindoleacetic acid, methyl ester

C14H19NO2Si (261.1185)


   

1H-Indole-2,3-dione, 7-propyl-1-(trimethylsilyl)-

1H-Indole-2,3-dione, 7-propyl-1-(trimethylsilyl)-

C14H19NO2Si (261.1185)


   

1H-Indole-2,3-dione, 5-isopropyl-1-(trimethylsilyl)-

1H-Indole-2,3-dione, 5-isopropyl-1-(trimethylsilyl)-

C14H19NO2Si (261.1185)


   

methapyrilene

methapyrilene

C14H19N3S (261.13)


R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AC - Substituted ethylene diamines D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist D018926 - Anti-Allergic Agents

   

O-succinylcarnitine

O-succinylcarnitine

C11H19NO6 (261.1212)


An O-acylcarnitine having succinyl as the acyl substituent.

   

Succinylcarnitine

Succinylcarnitine

C11H19NO6 (261.1212)


   

Suprofen glucuronide

Suprofen glucuronide

C11H19NO6 (261.1212)


   

O-methylmalonylcarnitine

O-methylmalonylcarnitine

C11H19NO6 (261.1212)


An O-acylcarnitine having methylmalonyl as the acyl substituent.

   

Methylmalonylcarnitine

Methylmalonylcarnitine

C11H19NO6 (261.1212)


   

O-methylmalonyl-L-carnitine

O-methylmalonyl-L-carnitine

C11H19NO6 (261.1212)


An O-acyl-L-carnitine in which the acyl group specified is methylmalonyl.

   

CAR DC3:0;2Me

CAR DC3:0;2Me

C11H19NO6 (261.1212)


   
   

CAR DC4:0/CAR DC3:0;2Me

CAR DC4:0/CAR DC3:0;2Me

C11H19NO6 (261.1212)


   
   

4,4-Diphenylbutylamine (hydrochloride)

4,4-Diphenylbutylamine (hydrochloride)

C16H20ClN (261.1284)


4,4-Diphenylbutylamine shows affinity for the 5-HT2A and H1 receptors with Kis of 2589 and 1670 nM, respectively[1].

   

(2r)-3-methyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

(2r)-3-methyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

(3s)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

(3s)-3-methyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

3-[(1,3-dihydroxypropan-2-yl)amino]-5-hydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-one

3-[(1,3-dihydroxypropan-2-yl)amino]-5-hydroxy-5-(hydroxymethyl)-2-methoxycyclohex-2-en-1-one

C11H19NO6 (261.1212)


   

3-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

3-methyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

2-[(1-carboxy-2-methylbutyl)amino]pentanedioic acid

2-[(1-carboxy-2-methylbutyl)amino]pentanedioic acid

C11H19NO6 (261.1212)


   

(2r)-2-methyl-2-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

(2r)-2-methyl-2-{[(2s,3s,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

2-methyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

2-methyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

2-[(1-carboxy-3-methylbutyl)amino]pentanedioic acid

2-[(1-carboxy-3-methylbutyl)amino]pentanedioic acid

C11H19NO6 (261.1212)


   

(s)-lotaustralin

(s)-lotaustralin

C11H19NO6 (261.1212)


   

(2s)-2-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

(2s)-2-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

C11H19NO6 (261.1212)


   

(12s)-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13,15,17-heptaene

(12s)-3,15,20-triazapentacyclo[10.7.1.0²,¹⁰.0⁴,⁹.0¹³,¹⁸]icosa-2(10),4,6,8,13,15,17-heptaene

C17H15N3 (261.1266)


   

3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

3-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

(2r)-2-{[(1s)-1-carboxy-3-methylbutyl]amino}pentanedioic acid

(2r)-2-{[(1s)-1-carboxy-3-methylbutyl]amino}pentanedioic acid

C11H19NO6 (261.1212)


   

(2s)-3-methyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

(2s)-3-methyl-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}butanenitrile

C11H19NO6 (261.1212)


   

(2e,4e,6e)-n-(2-methylpropyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

(2e,4e,6e)-n-(2-methylpropyl)-7-(thiophen-2-yl)hepta-2,4,6-trienimidic acid

C15H19NOS (261.1187)


   

(2r)-2-{[(1s,2s)-1-carboxy-2-methylbutyl]amino}pentanedioic acid

(2r)-2-{[(1s,2s)-1-carboxy-2-methylbutyl]amino}pentanedioic acid

C11H19NO6 (261.1212)


   

2-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

2-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)butanenitrile

C11H19NO6 (261.1212)


   

(2e)-n-(2-phenylethyl)dec-2-en-4,6,8-triynimidic acid

(2e)-n-(2-phenylethyl)dec-2-en-4,6,8-triynimidic acid

C18H15NO (261.1154)